For 60 years, sequence and structure has been the primary lens to understand protein function. It’s now time to look beyond and leverage the orchestration of protein function within cells. Cedilla Therapeutics is bringing a new dimension to precision oncology. We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional inhibitors are unlocking critical and elusive cancer targets including TEAD and CDK2. We are a driven and patient-focused team.
View Top Employees from Cedilla TherapeuticsWebsite | http://cedillatx.com |
Employees | 19 (19 on RocketReach) |
Founded | 2018 |
Address | 245 First Street 3rd Floor, Cambridge, Massachusetts 02142, US |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Protein, Life Sciences, Third Rock Ventures, Oncology, Science, Medicine, Team |
Looking for a particular Cedilla Therapeutics employee's phone or email?
Alan D'Andrea is the Co-Founder of Cedilla Therapeutics.
19 people are employed at Cedilla Therapeutics.
Cedilla Therapeutics is based in Cambridge, Massachusetts.